+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 75Years +
All Genders
ID07342023

Evaluation of GFAP and UCH-L1 Blood Tests to Improve Detection of Brain Bleeding in Hospitalized Older Adults with Recurrent Falls

Led by University Hospital, Clermont-Ferrand · Updated on 2026-10-26

770

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

This research focuses on patients aged 75 years and older who are hospitalized after experiencing recurrent falls. It aims to evaluate a personalized biological screening method using blood biomarkers to detect intracranial hemorrhages as an alternative to brain CT scans. Brain CT scans can be difficult to access quickly in elderly patients, making this study important to potentially improve timely diagnosis and care. Participants will have two blood tests measuring biomarkers GFAP and UCH-L1 using a portable device like the i-Stat Alinity. The first test happens within 72 hours of hospital admission to establish each patients baseline biomarker levels. If a participant falls again during hospitalization and a brain CT scan is recommended by the physician, a second blood test will be done within 6 to 12 hours after the fall, preferably before the CT scan, following national health guidelines. During the study, usual patient care continues without modification besides the blood tests. Researchers will collect data until the end of hospitalization for up to 28 days, measuring how well the personalized biomarker strategy detects intracranial bleeding compared to brain CT scans. They will also analyze results based on patient characteristics like age, sex, cognitive status, and medication use, as well as the potential impact on hospital resources.

CONDITIONS

Brief Title

Contribution of GFAP and UCH-L1 Assays in Whole Blood to Optimizing Personalized Care for "Repeated Fallers" Hospitalized in Geriatric Wards

Research Team

L

Lise Laclautre

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here